Premium
Functional Status and Quality of Life in Patients Surviving 10 years After Lung Transplantation
Author(s) -
Rutherford Robert M.,
Fisher Andrew J.,
Hilton Colin,
Forty Jonathan,
Hasan Asif,
Gould Francis K.,
Dark John H.,
Corris Paul A.
Publication year - 2005
Publication title -
american journal of transplantation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.89
H-Index - 188
eISSN - 1600-6143
pISSN - 1600-6135
DOI - 10.1111/j.1600-6143.2004.00803.x
Subject(s) - medicine , quality of life (healthcare) , transplantation , population , lung transplantation , physical therapy , nursing , environmental health
Although many lung allograft recipients achieve long‐term survival, there is a lack of published data regarding these patients' functional status and quality of life (QoL). We evaluated all 10‐year survivors at our institution and, utilizing the SF‐36 questionnaire, compared their QoL to population normative and chronic illness data. Twenty‐eight (29%) of 96 patients survived ≥10 years following 11 single, 6 bilateral and 11 heart‐lung procedures. At the most recent evaluation, median FEV 1 in single and double lung recipients was predicted to be 54% and 74%, respectively. Five (18%) patients had BOS score 0, 13 (46%) BOS 1, 5 (18%) BOS 2 and 5 (18%) BOS 3 and median time to BOS was 7 years. Four (14%) patients required renal replacement therapy. Three patients (11%) developed symptomatic osteoporosis, 2 (7%) post‐transplant lymphoma and 1 (4%) an ischaemic stroke. Scores for physical function, role‐physical/emotional and general health, but not mental health and bodily pain, were significantly lower compared to normative and chronic illness data. Energy and social‐function scores were significantly lower than normative data alone. Long‐term survival after lung transplantation is characterized by an absence or delayed development of BOS, low iatrogenic morbidity and preserved mental, but reduced physical health status.